首页 / 院系成果 / 成果详情页

TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo 期刊论文

编号：

c66293bc-1aa1-4adc-a850-10a3eaf747b6
作者：

Wu, Jing(吴静)#^[1]Li, Shuang^[1];Yang, Yang^[1];Zhu, Shan(朱珊)^[1]Zhang, Mingyou(张明友)^[2]Qiao, Yuan^[1];Liu, YongJun(刘勇军)^[1,3]Chen, Jingtao(陈京涛)*^[1]
语种：

英文
期刊：

ONCOTARGET ISSN：1949-2553 2017 年 8 卷 7 期 (11708 - 11718) ; FEB 14
收录：
关键词：

breast cancer plasmacytoid dendritic cells Toll-like receptor Imiquimod CpG
摘要：

Plasmacytoid dendritic cells (pDCs) are a unique subset of naturally occurring dendritic cells, which triggers the production of large amounts of type I interferons (IFNs) after viral infections through Toll-like receptor (TLR) 7 and TLR9. Recent studies have demonstrated that the activation of pDCs kills melanoma cells. However, the role of activated pDCs in breast cancer remains to be determined. In the present study, we generated mouse models of breast cancer and demonstrated that activated pDCs can directly kill breast tumor cells through TRAIL and Granzyme B. Furthermore, we established that pDCs initiate the sequential activation of NK cells and CD8(+) T cells, and ultimately inhibit breast tumor growth. Understanding the role of activated pDCs in breast cancer may help to develop new strategies for manipulating the function of pDCs and induce anti-tumor immunity in breast cancer.
推荐引用方式
GB/T 7714：

Wu Jing,Li Shuang,Yang Yang, et al. TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo [J].ONCOTARGET,2017,8(7):11708-11718.
APA：

Wu Jing,Li Shuang,Yang Yang,Zhu Shan,&Chen Jingtao.(2017).TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo .ONCOTARGET,8(7):11708-11718.
MLA：

Wu Jing, et al. "TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo" .ONCOTARGET 8,7(2017):11708-11718.
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：108  下载次数：0

分享到：

浏览次数：108

下载次数：0

打印次数：0